Table 4.
Variables cross-sectionally and longitudinally associated with plasma dihydrosphingomyelins in the Baltimore Longitudinal Study of Aging
C16:0 |
C18:0 |
C22:0 |
C24:0 |
|||||
---|---|---|---|---|---|---|---|---|
Baseline | Time-Dependent | Baseline | Time-Dependent | Baseline | Time-Dependent | Baseline | Time-Dependent | |
Covariates | b (SE) | b (SE) | b (SE) | b (SE) | b (SE) | b (SE) | b (SE) | b (SE) |
Age | 101.3 (15.6)c | 2785.5 (281.8)c | −3.0 (6.4) | 3.2 (20.3) | ||||
Age 2 | 0.5 (0.7) | 19.2 (15.6) | −1.6 (0.6)b | −3.0 (1.1)b | ||||
Men | −2795.9 (230.0)c | −14 287.7 (4130.0)b | 350.3 (125.1)b | −376.2 (261.6) | −51.6 (24.2)a | |||
African American | 19 115.4 (5822.6)b | 1007.3 (186.0)c | 3037.0 (378.9)c | |||||
BMI | 48.8 (21.0)b | 668.9 (454.1) | −13.4 (14.7) | 2.9 (1.5) | −42.3 (30.3) | |||
WHR | 2444.9 (1135.5)a | |||||||
Prediabetes | −232.4 (169.3) | −42.4 (16.6)a | −10 907.2 (3611.8)b | −725.1 (353.4)a | −492.9 (255.3) | |||
Diabetes | −52.5 (258.9) | −47.3 (24.3) | −8605.3 (5551.7) | −1136.3 (522.0)a | −273.1 (399.6) | |||
Statin use | 8238.3 (4166.0)a | |||||||
Cancer | 533.7 (237.8)c | 24 814.7 (5535.4)c | −1517.3 (544.6)b | 213.1 (399.6) | −79.4 (38.3)a | |||
Smoker | 205.1 (148.3) | −28.1 (14.2)a | ||||||
Cholesterol | 17.6 (2.0)c | 282.0 (42.3)c | 29.8 (1.5)c | 62.4 (3.0)c | ||||
Triglycerides | 4.5 (1.1)c | 130.2 (22.5)c | −2.8 (0.8)b | −6.3 (1.7)c | 0.3 (0.2) |
BMI, body mass index; WHR, waist–hip ratio.
We forced age, age 2, sex, and BMI into all models then used backward selection with P < 0.10 to determine which variables to include in the final model of each dihydrosphingomyelin carbon-chain length. aP < 0.05; bP < 0.01; cP < 0.001.